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Recently, some of the rules governing the in vitro activation of murine cytotoxic T-
lymphocytes (CTL)' have become unravelled (reviewed in 1, 2) . Accordingly, a
cascade of cell-cell interactions results in the activation of antigen-specific CTL-
precursors (CTL-P) (3-6) . The realization that biological mediators derived from
functionally distinct cell subsets involved in this process can be assayed separately
from their producer cells (7-13) has resulted in the Interleukin 2 concept (2, 5) as
depicted in Fig. 1 . Its salient feature is the observation that T cells require two signals
for activation . Signal 1, i.e ., antigen binding by clonally distributed antigen receptors,
does not represent an inductive signal, but renders the antigen-selected T cells sensitive
to the inductive signal 2 provided by Interleukins . Interleukins bind to nonclonally
distributed receptors on sensitive T cells, thereby initiatingT cell triggering . Accord-
ingly, the Lyt-1+ helper T cell-derived Interleukin 2 (Il-2 ; formerly T cell growth
factor [TCGF]) represents the inductive signal 2 for CTL-P (5, 12, 15, 16), whereas
the antigen-presenting cell (APC)-derived Interleukin 1 (Il-1 ; formerly lymphocyte-
activating factor [LAF]) represents the inductive signal 2 forT helper cells (5, 10, 11) .
There is also evidence that the release of Il-1 from APC is, in turn, controlled by a
mediator derived from inducer T cells (17) .
Since the Interleukin concept is entirely based on results obtained in vitro, little is
known about its relevance in vivo . Provided that it applies also in vivo, and assuming
that the nonspecific and nonrestricted 11-2 represents the inductive signal 2 for the in
vivo triggering process of clonally derived primary and secondary CTL-P, how then
is the specificity of CTL immune reactions maintained? What are the mechanisms
that control the nonspecific activity of II-2 in vivo, and possibly limit its activity to
close vicinity of the producer cell, thereby retaining the specificity ofCTL induction?
In an attempt to answer these questions, we searched for the presence of a putative
11-2 inhibitor in sera of normal mice . Here we describe the results obtained .
Materials and Methods
Mice. CBA/Ca, BALB/c, and C57BL/6 mice were obtained from OLAC Ltd ., Shaw's
Farm, Blackthorn, England . The breeding stock of the C57BL/6-congenic strain C57BL/6
* Supported by the SFB 107 Mainz and the Stiftung Volkswagenwerek.
$ Max-Planck-Institute of Immunology, Freiburg, Federal Republic of Germany.
1 Abbreviations used in this paper: APC, antigen-presenting cell ; ConA ; concanavalin A; CTL, cytotoxicT
lymphocytes ; CTL-P, cytotoxic T lymphocyte precursors ; FCS, fetal calf serum ; GVH, graft vs . host ; 11- 1,
Interleukin 1 ; Il-2, Interleukin 2 ; Kav, average association constant ; NMS, normal mouse serum ; PBS,
phosphate buffered saline ; PNA, peanut agglutinin .
zAt theSecond International Workshop, 1979, Ermatingen, Switzerland, asystem ofnomenclature was
introduced to term factors acting as communication signals between leukocytes (14) .
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￿
Minimal requirements of T-T cell interactions during the induction ofCTL. The Interleu-
kin concept : - - - -* indicates that antigen-binding (signal 1) renders the T cell sensitive to the
inductive signal of Interleukin (signal 2) . MW, molecular weight .
Lyta/Boy (B6/Lyt 1 .1) was kindly provided by Dr. E. A . Boyse, Memorial Sloan-Kettering
Cancer Center, New York. The C3H nu/nu mice were bred in the Max Planck Institute,
Freiburg, Federal Republic of Germany . Wistar rats were bred in our own animal facilities at
theJohannes Gutenberg University, Mainz, Federal Republic of Germany .
Treatment of Mice .
￿
Mice were x-irradiated with 950 rad (Philips RT 200 ; Fa . Miiller,
Frankfurt, Federal Republic of Germany) with a dose rate of 50 rad/min (whole-body
irradiation) . Mice were injected intraperitoneally with 60 mg/kgcyclophosphamide (Endoxan ;
ASTA-Werke, Bielefeld, Federal Republic of Germany) .
Semipurified Interleukin-2 (Il-2) .
￿
Il-2 was prepared from concanavalin A (Con A)-stimulated
lymphocyte culture supernate essentially as described (7) . In short, spleen cells (7 X 106/ml)
from mice or rats were cultured for 20-24 h in medium without fetal calf serum (FCS) in the
presence of I lug Con A/ml or 5 lugCon A/ml (Pharmacia Fine Chemicals, Uppsala, Sweden),
respectively . The supernate was concentrated by ultrafiltration with an Amicon YM-10
membrane (Amicon Corp ., Scientific Sys . Div., Lexington, Mass .) and theconcentrate applied
to a previously calibrated Sephadex G-100 column . Effluent fractions were tested for their
capacity to sustain growth of long-term CTL in vitro (7) . Active fractions were pooled,
concentrated, and kept frozen at -20°C.
11-2 Inhibitor.
￿
The source of Il-2 inhibitor was serum of normal inbred mice or inbred rats .
Serum was obtained by bleeding ether-anesthetized animals from the retroorbital sinus or by
cardiac puncture . Serumwas filter-sterilized through 0, 2lim Millipore filters (Millipore Corp .,
Bedford, Mass .) and used immediately or stored at 4°C.264
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Ammonium Sulfate Precipitation.
￿
Ammonium sulfate solution wasaddedto fresh normal mouse
serum (NMS) to 50% saturation. The mixture was allowed to stand overnight at 4°C. After
centrifugation, thesupernate was dialyzed extensively against 0.02M phosphate-buffered saline
(PBS, pH 7.4) and concentrated with an Amicon YM-10 ultrafiltration membrane.
Molecular Weight Estimation.
￿
Chromatography and molecular weight estimation was done
according to the Pharmacia Fine Chemicals Inc. instruction manual. Gel filtration was
performed at 4°C with Sephadex G-200 equilibrated with 0.02 M PBS (bed dimensions 1.76
X 100 cm). The sample vol was 1 ml and 2-ml fractions were collected. The column was
calibrated with marker proteins of knownmolecularweight (bovineserum albumin, ovalbumin,
and ribonuclease; gel filtration calibration kit; Pharmacia Fine Chemicals Inc.) and their
elution positions monitored by ultraviolet (A2so nm) absorbance.
The average association constant (Ke..) values of each protein were calculated using the
equation :
Ve - Vo
Vc - Vo
where Ve is theelution volume for the protein, Vo is the column void volume determined from
the elution volume of blue dextran 2000. Using semi-logarithmic graph paper, the Ka~ value
for each protein was plotted (linear scale) against the corresponding molecular weight (loga-
rithmic scale).
1 ml of nonprecipitable serum constituents [at 50% concentration of (NH4)2SO4] wasapplied
to the column and effluent fractions were dialyzed against medium. The elution position of Il-
2 inhibitor was determined by testing samples of fractions for their capacity to functionally
inactivate the effect of Il-2 on secondary cytotoxic T lymphocytes (7). The Ka values were
calculated and the molecular weightsdetermined from the calibration curve of marker proteins.
Antisera.
￿
Monoclonal anti-Lyt-1.1 antibodies were kindly provided by Dr. I. F. C. McKenzie
(Austin Hospital, Heidelberg, Victoria, Australia) and monoclonal Lyt-2.2 antibodies by Dr.
U. Hammerling (Memorial Sloan-Kettering Cancer Center). Monoclonal anti-Thy-1.2 antise-
rum was kindly provided by Dr. P. Lake (University College, London). Rabbit anti-mouse Ig
antibodies were obtained after immunization with purified mouseIg. Before use, the antiserum
was extensively absorbed with mouse thymocytes; thereafter, the titer was 1:400. The use of
anti-Lyt antisera hasbeen described elsewhere (7). Briefly, cells were resuspended in the diluted
antiserum at a concentration of 107 cells/ml and incubated for 30 min at 4°C, centrifuged,
resuspended in selected nontoxic rabbit complement diluted 1:12, and incubated for 45 min at
37°C. The number of viable cells remaining after treatment was determined by the dye
exclusion method. Dead cells were removed by centrifugation over Ficoll.
Purification of TandB Cells.
￿
T cells were purified by passageof spleen cellsover a nylon wool
column as described (18), B cells were obtained after treatment of spleen cells with anti-Thy-1
serum and complement.
Positive Selection ofLyt-/23+ Cells.
￿
As already described (16) virtually all peanut agglutinin
(PNA)-binding thymocytes express the Lyt-123+ phenotype. To positively select Lyt-123+ cells,
PNA-thymocytes were purified by cell-affinitychromatography accordingto themethod ofIrI6
et al. (19) as described (16). PNA-binding thymocytes were recovered by washing the column
with medium containing 0.15 M D(+)galactose. The PNA+ cells (>99% PNA+ in direct
immunofluorescence) proved to be all Lyt-123 positive, as tested in a complement-dependent
cytotoxicity assay with the appropriate anti-Lyt antisera.
Cell Culture andAssay of CTL
Ka = ,
CULTURE MEDIUM.
￿
A mixture of Click's and RPMI-1640 media (50% vol:vol) was supple-
mented with 10 mM Hepes, fresh glutamine, 5 X 10-5 M 2-mercaptoethanol, and 5% FCS.
SECONDARY MIXED LYMPHOCYTE CULTURES.
￿
3.5 X 106 spleen cells were cultured with 1.5 X
106 x-irradiated stimulator cells (2,000 rid, dose rate of 620 rid/min; Philips RT 200) in 2 ml
medium in multiculture plates (Linbro FB-24; TC; Linbro Chemical Co., Hamden, Conn.) in
a humified atmosphere of 5% C02 in air. At day six, 5 X 105 viable cells were restimulated with
2.5 X 106x-irradiated stimulator cells. After9 dof culture, cells were harvested and centrifuged
over Ficoll to remove dead cells.HARDT, ROLLINGHOFF, PFIZENMAIER, MOSMANN, AND WAGNER
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TEST FOR Il-2 INHIBITOR ACTIVITY .
￿
2 X 104secondary CTL were cultured in the presence of
an optimal concentration ofIl-2 . Il-2 inhibitor, i .e ., serum to be tested for inhibitor activity, was
added at the initiation of culture. At day 3, the CTL generated were tested for cytotoxic
activity .
TARGET CELLS .
￿
P815 (H-2 d) and EL4 (H-2) tumor cells were propagated in vitro .
CYTOTOXICITY ASSAY .
￿
Graded numbers of viable cells were harvested from mixed lympho-
cyte cultures and were incubated for 3 h with a constant number (5,000) 5'Cr-labeled target
cells as described elsewhere (13) . The percent specific lysis was calculated according to the
formula described previously (13) .
Results
Il-2 Inhibitor in the NMS. The Lyt-1 + helper T cell-derived Il-2 is functionally
defined by its capacity to induce and to sustain clonal expansion of 11-2-sensitive T-
cells (1, 2, 8, 20, 21) . In the present studies as test system for the putative Il-2 inhibitor
the inhibition of Il-2 driven, clonal expansion of alloreactive CTL was used . The
results depicted in Fig . 2 show that sera of adult mice contain high Il-2 inhibitory
activity, the activity of which, in turn, can be overcome by increasing concentrations
of Il-2 (Fig . 3) . Most interesting was that unlike NMS, the sera of athymic (nu/nu)
mice were found to be devoid of II-2 inhibitory activity (Fig. 2, 3) . In fact, sera ofnu/
nu mice supported expansion of alloreactive CTL equally well as FCS (Figs. 2, 3) .
These results provided circumstantial evidence that the Il-2 inhibitory activity in
NMS is dependent on an intact T cell system . Il-2 inhibitory activity was absent in
amniotic fluid and in sera taken from mouse embryos (Fig . 4) . Within 7 d after birth,
the serum concentration of 11-2 Inhibitor activity reached the level found in adult
mice (Fig . 4) . Sera of aged mice appear to have a reduced Il-2 inhibitory activity (Fig.
4) . Preliminary results indicated that sera of adult NZB mice prone to undergo
autoimmune reactions exhibit only -10-20% of II-2 inhibitory activity as compared
with normal mice (C . Hardt, unpublished data) .
Preliminary experiments have shown that Il-2 inhibitor was not precipitated by
(NH4)2SO4 up to 50% saturation . This allowed us to enrich for Il-2 inhibitor by
precipitating contaminating serum proteins at a (NH4)2SO4 concentration of 50%.
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Dose-dependent, 11-2-inhibitor activity in NMS . 2 X 10 4 primed CBA anti-BALB/c CTL
were cultured together with 50,al II-2 . Graded concentrations ofNMS (" ) or sera ofathymic nu/nu
mice (O) were titrated into the culture and cytolytic activity was determined on day 3 . Control
cultures received no mouse serum : A, positive control (with II-2) ; A, negative control (without II-2) .266
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Increasing amounts of Il-2 can overcome the II-2-inhibitor activity ofNMS . 2 X 10° primed
CBA anti-BALB/c CTL were cultured together with (") 2% NMS ; (O 10% nude mouse serum ; or
(") no mouse serum . Increasing amounts of Il-2 were titrated into the system and cytolytic activity
ofCTL generated was determined on day 3 . No CTL were generated in the absence of Il-2 .
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￿
Age dependency ofthe presence ofII-2 inhibitor in sera of normal mice . 2 X 10"CBA anti-
BALB/c primed T cells were cultured in the presence of 50 [l II-2 . NMS from unborn mice and
serum from mice of different ages were added to the cultures at final concentrations o£ 2.5% . Mouse
amniotic fluid was tested at a final concentration of 10%. After 3 d, CTL generated were tested for
their cytolytic activity in a 3-h 5'Cr-release assay .
Fractionated elution of nonprecipitable serum constituents on Sephadex G-200 al-
lowed estimation of the molecular weight of the Il-2 inhibitor . As shown in Fig. 5, the
Il-2 inhibitor eluted at ^-50,000 mot wt (Fig . 5) . The data given in Table I show that
the II-2 inhibitory activity is not H-2 restricted . In addition, the Il-2 inhibitory activity
is not linked to the antigen specificity of the T cell driven by Il-2 into clonal expansion .
However, the data presented here do not allow us to determine whether the Il-2
inhibitor neutralizes Il-2 in the fluid phase or after binding to its target cells. Titration
of the effect of either rat or mouse Il-2 inhibitor on mouse or rat Il-2 revealed no
detectable species specificity (Table II) . This finding is in agreement with the finding
that mouse Il-2 and rat Il-2, although different with regard to their molecular weights
(22), do not exhibit species specificity .N
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Dextran blue
￿
albumin
￿
Ovalbumin
￿
Ribonuclease
2.000 000 MW
￿
67 .000 MW
￿
43,000 MW
￿
13700 MW
13 .7
￿
43 50 67 MW z 10'
(log)
Bovine serum
FiG . 5 .
￿
Molecular weight estimation of II-2 inhibitor by elution from a Sephadex G-200 column .
See Materials and Methods for details. MW, molecular weight .
TABLE I
Nonspecificity ofIl-2 Inhibitor
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mouse mouse
Fractions of G200 column
￿
control serum
serum
2 X 104 primedCTL were cultured together with 50 ttl Il-2 (derived from H-2a spleen
cells), 5% FCS, andNMS as indicated. Cytolytic activity ofCTL generated was tested
on day 3 . Percent inhibition is calculated from the reduction of percent specific lysis
relative to the control culture-where no serum was added . Percent specific lysis of II-
2 test cells was, depending on the group, between 65 and 94% .
Characteristics of Cells Controlling the In Vivo Activity of Il-2 Inhibitor.
￿
As already
discussed, sera of athymic (nu/nu) mice lack the I1-2 inhibitor (Figs. 2, 3) . In addition,
3-4 d after whole-body irradiation (950 rad) of normal mice, the I1-2 inhibitor
disappeared (Fig . 6) . Taken together these results suggested that T cells control the in
vivo activity of the Il-2 inhibitor and that there exists in vivo a delicate balance
between 11-2-inhibitor production and its clearance . To define more precisely the role
ofT cells for the production of the I1-2 inhibitor, cell transfer experiments into nu/nu
mice were performed . The results given in Fig . 7 demonstrate that unlike syngeneic
Il-2 test cells
Il-2 inhibitor from
normal mice
Percent
5%
serum
inhibition
presence of
2.5%
serum
in the
0.5%
serum
CBA anti-BALB/c CBA 100 48 0
BALB/c 100 35 0
CBA anti-C57BL/6 CBA 99 48 0
BALB/c 97 30 0
C57BL/6 anti-BALB/c CBA 100 40 0
BALB/c 96 24 0268
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2 X 104 primed T cells from mouse or rat sera were cultured in the presence of 50 ttl Il-2 (Con
A-induced II-2 from mouse or rat spleen cells) and 5% FCS. As source of Il-2 inhibitor, NMS
or rat serum was added to final concentrations as indicated. Cytolytic activity of CTL was
determined on day 3. Percent inhibition is expressed as the reduction of percent specific lysis
relative to the cultured cells to which no serum was added. Percent specific lysis of the control
culture: A, 83%; B, 93%; C, 61%; D, 64%.
TABLE II
Lack ofSpecificity ofInterleukin-2 Inhibitorfrom Mouse and Rat Sera
Il-2 inhibitor
INTERLEUKIN-2 INHIBITOR
CTL: CBA
Percent inhibition
days after irradiation( 950
￿
rad )
FIG. 6.
￿
Effect ofwhole-body irradiation on the concentration of serum-borne Il-2 inhibitor. 6-wk-
old CBA mice were x-irradiated with 950 rad. At the time intervals given, three mice per group
were bled from the retroorbital sinus and the serum stored at 4°C. All sera obtained were tested
together for inhibitor activity as detailed in Materials and Methods.
Percent
serum
(mouse)
BALB/c
Mouse
anti-
Rat I1-2
CTL:
anti-BALB/c
Mouse
Wistar (rat)
Rat II-2
20.0 100 100 100 100
10.0 100 94 100 100
5.0 99 80 100 100
2.5 63 42 50 70
0.5 0 0 9 15
20.0 94 75 100 100
10.0 42 12 59 49
5.0 0 0 53 42
2.5 0 0 17 27
0.5 0 0 0 0HARDT, RÖLLINGHOFF, PFIZENMAIER, MOSMANN, AND WAGNER
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T cell-dependent induction of Il-2 inhibitor in sera of athymic mice . Groups of nine C3H
nu/nu mice were grafted with 3 X 10 7 cells as depicted. ", Allogeneic C57BL/6 T cells (>95% T
cells) ; O, allogeneic C57BL/6 T cells, 2,000-rad irradiated (>95% T cells) ; A, syngeneic C3HT cells
(>95% T-cells) ; A, allogeneic C57BL/6 B cells (>99% B cells) ; N, no cells ; 0, control of normal
C3H mouse serum . At the time points indicated, mice were bled and the sera stored at 4°C .
Thereafter, the sera were tested for II-2 inhibitory activity.
T cells, upon transfer of allogeneic T cells, the sera of the recipient nu/nu mice
contain high levels of Il-2 inhibitor activity within 3 d . Interestingly, the serum
activity of Il-2 inhibitor has almost disappeared 7-12 d after transfer of allogeneic T
cells .
Because nu/nu mice are able to reject grafted allogeneic T cells within 7-8 d (23,
24) and because the data depicted in Fig. 6 have suggested an 11-2-inhibitor clearance
time from the sera of-3-5 d, the data given in Fig . 7 provide circumstantial evidence
that the I1-2 inhibitor is derived from the grafted allogeneic T cells . Moreover, only
the Lyt-23+ T cell subset, but not Lyt-1+ T cells, appeared to be endowed with the
capacity to induce Il-2 inhibitor activity in the sera of recipient nu/nu mice in a
graft-vs.-host (GVH) reaction (Fig . 8) . Because pretreatment of normal CBA mice
with moderate doses (60 mg/kg) of cyclophosphamide, a protocol previously shown
to affect primarily T suppressor cells (25, 26) also resulted in a dramatic decrease of
I1-2 inhibitor activity (Fig . 9), we conclude that the Il-2 inhibitor is controlled by a
cyclophosphamide-sensitive Lyt-23' T cell in vivo .
Discussion
We have identified an Il-2 inhibitor with an ^50,000 mol wt in NMS . Sera of
athymic (nu/nu) mice lack the Il-2 inhibitor . II-2 inhibitor appearance was found to
be age related and thoroughly dependent on the reactivity of cyclophosphamide-
sensitive Lyt-23+ T cells . The functional activity of the 11-2 inhibitor appeared to be
neither H-2 restricted, nor antigen specific, nor species restricted, at least between270
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Ly-1 congenic, nylon wool-nonadherent C57BL/6 spleen cells were treated with anti-Ly
1.1 or anti-Ly 2.2 antiserum and complement or left untreated . As a source of Ly-123+ T cells,
PNA' thymocytes (12) were used. Groups of two individual C3H mice were grafted with either 35
X 106 untreated C57BL/6T cells, 30 X 106 PNA' Ly-123` thymocytes, 12 X 106 Ly-23' C57BL/6,
or 24 X 10 6 Ly-1' C57BL/6T cells . 3 d after cell transfer, individual mice were bled, sera were
pooled per group, and tested for the presence ofIl-2 inhibitor as detailed in Materialsand Methods .
no serum
￿
no 11-2
￿
7.5
￿
5.0
￿
2.5
￿
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￿
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￿
5.0
￿
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￿
0.5'%
controls
￿
sera from normal mice
￿
sera from Cy-treated mice
FIG . 9 . CBA mice were either injected for 3 consecutive d intraperitoneally with 60 mg/kg
cyclophosphamide (Cy) or with an equivalent vol of NaCl . The mice were bled 24 h later, and their
sera tested at graded concentrations for the presence of II-2 inhibitor activity .
mouse and rat . However, further analysis is required to establish a similar pattern of
species restriction as described for 11-2 (27) for the 11-2 inhibitor . Because of the
recently recognized central role of the Lyt-1 + helper T cell-derived 11-2 as inductive
signal 2 (Fig . 1) in the in vitro triggering process of antigen-specific CTL-P (1-9), and
because of the nonspecific and unrestricted function of 11-2 (5, 6, 13), we postulated
that under in vivo conditions, regulatory mechanisms must exist as a consequence of
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which the functional activity of I1-2 is limited to close proximity of its producer cells,
thereby avoiding induction of third-party 11-2-sensitive CTL-P.
This report is first to describe high endogenous levels of Il-2 inhibitor activity in the
sera of normal mice. Its absence in the amniotic fluid, its rise in the early postnatal
period, its ^-50,000 mol wt, and its capacity to selectively neutralize II-2 activity
excludes the possibility that we are dealing with alpha-fetoprotein, which is known to
induce suppressor T cells (28, 29) . The absence of Il-2 inhibitor in athymic nu/nu
mice, and its appearance in the course of a GVH reaction mediated by allogeneic
Lyt-23+ T cells strongly points out that only in the course ofactivation of the Lyt-23+
T cell subset, Il-2 inhibitor activity can be detected in the serum of recipient nu/nu
mice. It is well known that the Lyt-23+ T cell subset includes effector cells of the T
suppressor circuit (30, 31) .
The presence of Il-2 inhibitor in sera of normal unprimed mice implies a permanent
in vivo stimulation of the 11-2-inhibitor-producer cells. The observation that a
cyclophosphamide-sensitive Lyt-23+ T cell is required for its production provides
additional circumstantial evidence that the Il-2 inhibitor, in fact, represents a non-
specific effector molecule derived from suppressor T cells.
Although further experimentation is required for a precise analysis of the cell
producing the Il-2 inhibitor and of the mode ofaction of the inhibitor on Il-2 activity,
the results discussed here provide compelling evidence for the existence of a cyclo-
phosphamide-sensitive T cell regulatory system able to neutralize in vivo the activity
of II-2. Because in NMS the II-2 inhibitor activity is high, the functional activity of
the helper T cell-derived Il-2 will be restricted, in vivo, to its site of production. It
follows then that a close proximity between helper T cells and CTL-P is required for
effective in vivo CTL induction to occur.
The presence of high concentrations ofIl-2 inhibitor activity in sera of normal mice
poses limitations on a protocol aimed at boosting CTL responsiveness toward weakly
immunogenic antigens by systemic or local applications of II-2 in vivo. According to
our experience (32), the amplifying effect of exogenous Il-2 on the in vivo CTL
responsiveness toward trinitrophenyl-conjugated syngeneic cells was rather poor.
Obviously, the prospects of such a protocol could be improved by either pretreatment
of the recipient with low doses ofcyclophosphamide, a maneuvre known to selectively
paralize suppressor T cells (25, 26) and shown here to reduce dramatically the activity
of Il-2 inhibitor (Fig. 9) .
Alternatively, a good prospect is conceivable in in vivo situations characterized by
a lack ofII-2 inhibitor. Indeed, we recently could show a dramatic effect ofsystemically
applied exogenous II-2 on both the in vivo CTL responsiveness (24) and the helper T
cell responsiveness (33) of athymic nu/nu mice in vivo.
The relation of the II-2 inhibitor described here with immunosuppressive factors
described in the literature (34-38) is yet unknown. It is also unclear whether the Il-2
inhibitor described here is related to the nonspecific product of cloned suppressor T
cells, as analyzed by Cantor et al . (39) . To study these questions there is an obvious
need to establish in vitro conditions that allow production of the II-2 inhibitor from
their producer cell . The existence of the II-2 inhibitor in sera of normal mice may
explain the low in vivo primary CTL responsiveness (40-42). The observation that 3-
4 d after whole-body irradiation of normal mice, the serum-borne Il-2 inhibitor
activity disappears (Fig. 6) might also explain why in the spleen of irradiated (A X272
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B)F1 mice, but not in those of normal (A X B)F1 mice, highly alloreactive CTL are
present, provided the mice have been injected with parental type of responder T cells
(43). On the basis of the results described here, we propose that the relative concen-
tration of I1-2 vs. Il-2 inhibitor will decide whether or not the inductive signal 2 for
the activation of CTL-P is available in vivo.
Summary
Sera of thymus-bearing normal mice contain high levels of Interleukin 2 (11-2)
inhibitor, whereas sera of athymic nu/nu mice do not. Evidence is presented that
cyclophosphamide-sensitive Lyt-23' T cells induce high Il-2 inhibitor activity in the
recipient nu/nu mice in the course of a graft-vs.-host reaction. The Il-2 inhibitor has
an 50,000 mol wt. Its function is neither antigen specific nor H-2 restricted. During
ontogeny, its activity parallels the development of T cell reactivity, i.e., it is absent
both in the amniotic fluid and in sera of unborn mice, but increases to high levels
during the early postnatal phase.
The Il-2 inhibitor described is viewed as an example of a T cell-dependent, in vivo
regulatory mechanism able to effectively counteract the nonspecific activity of the
Lyt-1 + helper T cell-derived Il-2. Because the Il-2 inhibitor activity is rather high in
vivo, Il-2 activity will exist only in close proximity to its producer cell, thereby
maintaining specificity during the in vivo induction of cytotoxic T lymphocytes.
Receivedforpublication 14 April 1981.
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